| Firm | Analyst |
|---|---|
| B. Riley Securities | Madison El-Saadi, Ph.D. |
| Oppenheimer & Co. Inc. | Leland Gershell, M.D., Ph.D. |
| Ladenburg Thalmann & Co. Inc. | Aydin Huseynov, M.D., CFA |
| Cantor Fitzgerald & Co. | Kristen Kluska |
| Maxim Group | Jason McCarthy, Ph.D. |
| JonesTrading | Catherine Novack |
| ROTH Capital Partners | Boobalan Pachaiyappan, Ph.D. |
| H.C. Wainwright & Co. | Joseph Pantginis, Ph.D. |
| Piper Sandler & Co. | Edward A. Tenthoff |
Capricor Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Capricor’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Capricor or its management. Capricor does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.